GRAIL · 2 weeks ago
Senior Medical Science Liaison / Medical Science Liaison (Great Lakes - Michigan, Ohio, Indiana, Western Pennsylvania and Kentucky) # 4463
GRAIL is a healthcare company dedicated to early cancer detection through innovative technologies. The Senior Medical Science Liaison will engage and educate healthcare providers on the Galleri Multi-Cancer Early Detection test while ensuring compliance with corporate and healthcare guidelines.
BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Responsibilities
Develop and/or maintain strong educational and collaborative working relationships with key primary care providers, diagnostic specialists, oncologists, KOLs, HCS decision makers, and national/regional professional societies to support understanding and adoption of the Galleri MCED Test
Maintain in-depth clinical, scientific, and technical expertise related to GRAIL’s products, cancer screening, and cancer diagnostic guidelines through continuous learning, participating in various internal and external clinical and scientific education programs, meetings, presentations, and other forums
Engage in continuous learning, actively attend and participate in up-skilling training programs, utilize appropriate resources, meetings, presentations and other forums that provide operational expertise
Support ordering providers and diagnostic specialists with appropriate and compliant educational materials for Galleri post-positive patient journey support
Summarize and communicate complex medical messages to enable clear and concise understanding by both external audiences and partners within GRAIL
Through external engagements, elicit, capture and document actionable insights relevant to GRAIL strategy
Participate in local, regional, and national meetings in support of all scientific and medical objectives
Qualification
Required
Advanced scientific degree (PhD, PharmD, MD, NP, PA, CGC, or equivalent degree)
3 + years of external-facing industry experience in a diagnostics or pharmaceutical Medical Affairs setting required
Advanced knowledge of the biotechnology, diagnostics, and/or pharmaceutical industry required
Ability to apply advanced knowledge of GRAIL's product specifications required
Extensive travel required up to 3-4 days per week to meet with KOLs, attend physician education talks and conferences, including specialty society scientific meetings (will require some weekend work). Travel is estimated to be approximately 60%
Preferred
Experience in oncology, genomics, diagnostics, cfDNA-based fields strongly preferred
Ability to work independently and remotely while maintaining a strong teamwork mentality is preferred
Flexible to changes in a dynamic corporate environment is preferred
Multi-dimensional in abilities to work on simultaneous tasks in a high-paced environment is preferred
Strong problem-solving skills, good attention to detail, time management skills is preferred
Learning mindset, open to training and becoming an expert across customer types is preferred
Excellent communication and presentation skills; exhibits professional maturity, confidence, and competence is preferred
Highly developed written skills, and the ability to produce documents for dissemination both inside and outside the organization for presentations, technical briefs is preferred
Ability to elicit and answer clinical questions in groups ranging from individuals to larger didactic roundtables and podium presentations is preferred
Ability to address high-level experts in the scientific field at company-sponsored events and scientific conferences is preferred
Benefits
Flexible time-off
A 401(k) with a company % match
Medical, dental, and vision insurance plans
Carefully selected mindfulness offerings
Company
GRAIL
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Funding
Current Stage
Public CompanyTotal Funding
$2.44BKey Investors
ARCH Venture PartnersIllumina
2025-10-20Post Ipo Equity· $325M
2025-10-16Post Ipo Equity· $110M
2024-06-13IPO
Leadership Team
Recent News
2026-01-16
2026-01-14
2026-01-13
Company data provided by crunchbase